IEPA 11

Jacqueline Mayoral-van Son1,3,6, Maria Juncal Ruiz1, Victor Ortiz-García de la Foz6, David Cantarero4, Carla Blázquez4, María Paz5, Paula Paras5, Benedicto Crespo-Facorro2,3,6; 1Department of Psychiatry, Sierrallana Hospital,Cantabria. Spain., 2Department of Psychiatry, University Hospital Marqués de Valdecilla, Santander. Spain, 3School of Medicine. University of Cantabria. Spain., 4School of Economics. University of Cantabria, GIECONPSALUD., 5Nursing School, University of Cantabria. Spain, 6CIBERSAM. IDIVAL

Objective. Early-intervention psychiatric services in patients with psychosis aim to limit the most damaging outcomes, and reduce the risk of social drift of the patient, decreasing illness severity and hence contain healthcare costs. There is a scarcity of studies which focuses on FEP, and those ones published, only looked for direct health costs but not for indirect costs, which are the bulk of the budget. Our study aims to explore the economic cost of a First Episode of Psychosis Program in short term (1 year follow up) including direct and indirect costs. Methods     The study is a retrospective data collection from clinical records of  157 patients included in PAFIP (Programa Atención Fases Iniciales de Psicosis), from the University Hospital Marqués Valdecilla, Santander. Our data collection sheet included data from direct and indirect costs associated to the illness. Data were also extracted from the Cantabria Health Service Records. STATA 15.0 was used for statistical analysis. Results     On average, the total costs during the first year were €48,277.51 being Direct Health Care costs €13,729.47 (28.45%) , direct non-medical costs €108.6( 0.22%) and indirect costs €34,439.44 (71.3%).     We found that hospitalization costs were higher in males (p=0.081), cannabis use increased hospitalization costs (p=0.032). The number of relapses increased both, hospitalization and treatment costs (r=0.40 and p=0.000; r=0.24 and p=0.067). Conclusions     Intensive Early Intervention Programs in psychosis may result in cost savings by decreasing hospitalization, premature mortality, disability, unemployment, and legal problems although first year after diagnosis would represent the one which higher costs.